Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis.

PubWeight™: 4.09‹?› | Rank: Top 1%

🔗 View Article (PMID 17383417)

Published in Gastroenterology on January 31, 2007

Authors

Ralf Kiesslich1, Martin Goetz, Katharina Lammersdorf, Constantin Schneider, Juergen Burg, Manfred Stolte, Michael Vieth, Bernhard Nafe, Peter R Galle, Markus F Neurath

Author Affiliations

1: I. Medical Clinic, Johannes Gutenberg University of Mainz, Germany. info@ralf-kiesslich.de

Associated clinical trials:

Confocal Laser Endomicroscopy Findings in Patients With Proctosigmoiditis Before and After Initiation of Treatment | NCT01684514

Endocytoscopy and Colorectal Neoplasia | NCT02324374

Endomicroscopy and Gastric MALT-lymphoma | NCT01583699

Endomicroscopy in Patients With Food Allergy: a New Diagnostic Option | NCT01072084

Articles citing this

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease. Nat Med (2014) 2.54

Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study. Am J Gastroenterol (2015) 2.35

Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo. Gut (2010) 1.92

Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol (2008) 1.79

Evaluation of quantitative image analysis criteria for the high-resolution microendoscopic detection of neoplasia in Barrett's esophagus. J Biomed Opt (2010) 1.76

Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut (2008) 1.59

Multiphoton imaging can be used for microscopic examination of intact human gastrointestinal mucosa ex vivo. Clin Gastroenterol Hepatol (2007) 1.56

Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol (2008) 1.30

Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J Gastroenterol (2011) 1.23

Current management of inflammatory bowel disease and colorectal cancer. Gastrointest Cancer Res (2011) 1.21

Recent advances of endoscopy in inflammatory bowel diseases. Gut Liver (2007) 1.17

Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. World J Gastroenterol (2014) 1.16

New imaging techniques and opportunities in endoscopy. Nat Rev Gastroenterol Hepatol (2011) 1.15

Confocal laser endomicroscopy and immunoendoscopy for real-time assessment of vascularization in gastrointestinal malignancies. World J Gastroenterol (2011) 1.14

In vivo diagnostic accuracy of high-resolution microendoscopy in differentiating neoplastic from non-neoplastic colorectal polyps: a prospective study. Am J Gastroenterol (2013) 1.13

Future directions for the early detection of colorectal cancer recurrence. J Cancer (2014) 1.05

New endoscopic approaches in IBD. World J Gastroenterol (2011) 1.04

Endoscopic imaging: How far are we from real-time histology? World J Gastrointest Endosc (2011) 1.04

Use of probe-based confocal laser endomicroscopy (pCLE) in gastrointestinal applications. A consensus report based on clinical evidence. United European Gastroenterol J (2015) 0.99

Colon cancer screening and surveillance in inflammatory bowel disease. Clin Endosc (2014) 0.95

In-vivo characterization of DALM in ulcerative colitis with high-resolution probe-based confocal laser endomicroscopy. World J Gastroenterol (2011) 0.95

Diagnostic accuracy of confocal laser endomicroscopy in diagnosing dysplasia in patients affected by long-standing ulcerative colitis. World J Gastrointest Endosc (2012) 0.95

Colorectal cancer in inflammatory bowel disease. Gut Liver (2008) 0.94

Inflammatory Bowel Disease-related Colorectal Cancer in the Asia-Pacific Region: Past, Present, and Future. Intest Res (2014) 0.93

Emerging technologies in upper gastrointestinal endoscopy and celiac disease. Nat Clin Pract Gastroenterol Hepatol (2008) 0.93

Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol (2014) 0.92

Fluorescence endoscopy of cathepsin activity discriminates dysplasia from colitis. Inflamm Bowel Dis (2013) 0.90

Vital-dye enhanced fluorescence imaging of GI mucosa: metaplasia, neoplasia, inflammation. Gastrointest Endosc (2012) 0.90

Sacral nerve stimulation enhances early intestinal mucosal repair following mucosal injury in a pig model. J Physiol (2016) 0.89

New aspects of modern endoscopy. World J Gastrointest Endosc (2014) 0.87

Confocal Laser Endomicroscopy in the Study of Colonic Mucosa in IBD Patients: A Review. Gastroenterol Res Pract (2012) 0.86

Techniques for targeting screening in ulcerative colitis. Postgrad Med J (2007) 0.86

Endoscopic and histologic characteristics of serrated lesions. World J Gastroenterol (2015) 0.85

Colorectal cancer surveillance in patients with inflammatory bowel disease: What is new? World J Gastrointest Endosc (2012) 0.85

Confocal Laser Endomicroscopy in Gastrointestinal and Pancreatobiliary Diseases: A Systematic Review and Meta-Analysis. Biomed Res Int (2016) 0.84

Exploring the optimal fluorescein dose in probe-based confocal laser endomicroscopy for colonic imaging. J Interv Gastroenterol (2011) 0.84

Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer. Br J Cancer (2013) 0.84

Correlation between endocytoscopy and conventional histopathology in microstructural features of ulcerative colitis. J Gastroenterol (2011) 0.83

Endoscopic and pathological aspects of colitis-associated dysplasia. Nat Rev Gastroenterol Hepatol (2009) 0.83

Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers. Nat Clin Pract Gastroenterol Hepatol (2009) 0.83

Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols. Int J Colorectal Dis (2011) 0.82

Indications, stains and techniques in chromoendoscopy. QJM (2012) 0.82

Use of confocal laser endomicroscopy to predict relapse of ulcerative colitis. BMC Gastroenterol (2014) 0.82

Confocal laser endomicroscopy in inflammatory bowel diseases: dream or reality? World J Gastroenterol (2013) 0.82

Advanced therapeutic endoscopist and inflammatory bowel disease: dawn of a new role. World J Gastroenterol (2014) 0.81

Surveillance programmes for neoplasia in colitis. J Gastroenterol (2010) 0.81

Advanced endoscopic imaging for diagnosis of Crohn's disease. Gastroenterol Res Pract (2011) 0.81

Colonoscopic Cancer Surveillance in Inflammatory Bowel Disease: What's New Beyond Random Biopsy? Clin Endosc (2012) 0.80

In vivo classification of colorectal neoplasia using high-resolution microendoscopy: Improvement with experience. J Gastroenterol Hepatol (2015) 0.80

Colorectal cancer and Crohn's colitis: clinical implications from 313 surgical patients. World J Surg (2013) 0.80

The current and future role of endomicroscopy in the management of inflammatory bowel disease. Ann Gastroenterol (2015) 0.80

Beyond white light endoscopy: the role of optical biopsy in inflammatory bowel disease. World J Gastroenterol (2013) 0.79

Is chromoendoscopy the new standard for cancer surveillance in patients with ulcerative colitis? Nat Clin Pract Gastroenterol Hepatol (2009) 0.79

Advances in the diagnosis and management of inflammatory bowel disease: challenges and uncertainties. Saudi J Gastroenterol (2014) 0.79

Recent trends in diagnostic techniques for inflammatory bowel disease. Korean J Intern Med (2015) 0.79

Chromoendoscopy and Advanced Imaging Technologies for Surveillance of Patients with IBD. Gastroenterol Hepatol (N Y) (2012) 0.79

[Intraepithelial neoplasia/dysplasia - histopathology in ulcerative colitis]. Pathologe (2008) 0.79

Diagnostic yield of endomicroscopy for dysplasia in primary sclerosing cholangitis associated inflammatory bowel disease: a feasibility study. Endosc Int Open (2016) 0.77

Propofol vs midazolam plus fentanyl for upper gastrointestinal endomicroscopy: a randomized trial. World J Gastroenterol (2012) 0.77

Random versus targeted biopsies for colorectal cancer surveillance in inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2010) 0.77

New endoscopic imaging techniques in surveillance of inflammatory bowel disease. World J Gastrointest Endosc (2015) 0.77

Confocal endomicroscopy: Is it time to move on? World J Gastrointest Endosc (2016) 0.76

Advances in the Endoscopic Assessment of Inflammatory Bowel Diseases: Cooperation between Endoscopic and Pathologic Evaluations. J Pathol Transl Med (2015) 0.76

Novel application of low pH-dependent fluorescent dyes to examine colitis. BMC Gastroenterol (2010) 0.75

Advanced gastrointestinal endoscopic imaging for inflammatory bowel diseases. World J Gastroenterol (2016) 0.75

From the surface to the single cell: Novel endoscopic approaches in inflammatory bowel disease. World J Gastroenterol (2015) 0.75

Magnification pan-chromoendoscopy remains the mainstay for colitis dysplasia detection and differentiation. Gastroenterology (2007) 0.75

The use of optical imaging techniques in the gastrointestinal tract. Frontline Gastroenterol (2015) 0.75

Endoscopic Therapy in Inflammatory Bowel Diseases. Viszeralmedizin (2015) 0.75

A guide to multimodal endoscopy imaging for gastrointestinal malignancy - an early indicator. Nat Rev Gastroenterol Hepatol (2017) 0.75

Screening: Endomicroscopy for a reliable diagnosis of colorectal neoplasia. Nat Rev Gastroenterol Hepatol (2010) 0.75

Confocal endomicroscopy (CEM) improves efficiency of Barrett surveillance. J Interv Gastroenterol (2012) 0.75

Endoscopy in inflammatory bowel disease when and why. World J Gastrointest Endosc (2012) 0.75

Light and sound - emerging imaging techniques for inflammatory bowel disease. World J Gastroenterol (2016) 0.75

Bringing top-end endoscopy to regional australia: hurdles and benefits. Diagn Ther Endosc (2012) 0.75

Chromoendoscopy and Dysplasia Surveillance in Inflammatory Bowel Disease: Past, Present, and Future. Gastroenterol Hepatol (N Y) (2015) 0.75

Evolving protocols in colorectal cancer surveillance. Gastroenterol Hepatol (N Y) (2008) 0.75

Confocal laser endomicroscopy and NSAID enteropathy: where next? Dig Dis Sci (2014) 0.75

Quantitative evaluation of in vivo vital-dye fluorescence endoscopic imaging for the detection of Barrett's-associated neoplasia. J Biomed Opt (2015) 0.75

How useful is combined chromoendoscopy and endomicroscopy in patients with ulcerative colitis? Nat Clin Pract Gastroenterol Hepatol (2007) 0.75

Histopathological confirmation of similar intramucosal distribution of fluorescein in both intravenous administration and local mucosal application for probe-based confocal laser endomicroscopy of the normal stomach. World J Clin Cases (2015) 0.75

Interval colorectal carcinoma: An unsolved debate. World J Gastroenterol (2015) 0.75

Confocal chromolaser endomicroscopy: a supplemental diagnostic tool prior to transanal endoscopic microsurgery of rectal tumors? Int J Colorectal Dis (2009) 0.75

Endoscopic Surveillance in Long-standing Colitis. Curr Treat Options Gastroenterol (2017) 0.75

Advanced imaging in colonoscopy: contemporary approach to dysplasia surveillance in inflammatory bowel disease. Frontline Gastroenterol (2016) 0.75

Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis: a Japanese nationwide randomized controlled trial. J Gastroenterol (2010) 0.75

Advances in the Diagnosis and Management of Colonic Dysplasia in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) (2017) 0.75

Detection of colonic dysplasia in patients with ulcerative colitis using a targeted fluorescent peptide and confocal laser endomicroscopy: A pilot study. PLoS One (2017) 0.75

A pilot study of confocal laser endomicroscopy for diagnosing gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma. Surg Endosc (2015) 0.75

Stereomicroscopic features of colitis-associated tumors in mice: Evaluation of pit pattern. Oncol Lett (2017) 0.75

The Role of Chromoendoscopy in Evaluating Colorectal Dysplasia. Gastroenterol Hepatol (N Y) (2017) 0.75

Probe-based confocal laser microscopy identifies criteria predictive of active celiac sprue. Dig Dis Sci (2011) 0.75

Articles by these authors

Sorafenib in advanced hepatocellular carcinoma. N Engl J Med (2008) 54.30

Chemically induced mouse models of intestinal inflammation. Nat Protoc (2007) 8.65

Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med (2004) 7.93

Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol (2004) 7.41

Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature (2007) 7.17

Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. N Engl J Med (2015) 6.71

Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology (2004) 6.60

Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology (2008) 6.35

Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology (2005) 5.77

Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology (2003) 5.11

STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med (2009) 4.94

Colorectal cancer. Lancet (2005) 4.90

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity (2004) 4.48

Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc (2007) 4.28

Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science (2002) 3.91

An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc (2007) 3.81

The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology (2006) 3.80

A fluorescence confocal endomicroscope for in vivo microscopy of the upper- and the lower-GI tract. Gastrointest Endosc (2005) 3.79

Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest (2003) 3.73

In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol (2006) 3.69

Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature (2011) 3.61

Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol (2002) 3.41

Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm Bowel Dis (2006) 3.29

Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol (2008) 3.27

Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol (2006) 3.18

RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology (2008) 3.13

Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation. Am J Gastroenterol (2006) 3.11

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. J Hepatol (2012) 3.04

CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest (2003) 2.97

The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J Clin Invest (2005) 2.91

Eccentric loading, shock-wave treatment, or a wait-and-see policy for tendinopathy of the main body of tendo Achillis: a randomized controlled trial. Am J Sports Med (2007) 2.77

Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc (2007) 2.75

Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J Immunol (2006) 2.74

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68

Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med (2006) 2.53

A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc (2003) 2.47

Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology (2012) 2.46

Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol (2005) 2.45

Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev (2007) 2.42

In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor. Gastroenterology (2009) 2.33

Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol (2004) 2.22

Description of a new, endoscopic technique to remove the over-the-scope-clip in an ex vivo porcine model (with video). Gastrointest Endosc (2012) 2.22

Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology (2009) 2.19

Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology (2009) 2.16

Influence of subclinical tumor spreading on survival after curative surgery for colorectal cancer. Arch Surg (2008) 2.16

Coexistence of Cullen's and Grey Turner's signs in acute pancreatitis. Am J Med (2009) 2.13

High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol (2005) 2.13

Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol (2004) 2.09

Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol (2009) 2.09

Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc (2008) 2.09

Confocal laser endomicroscopy: technical advances and clinical applications. Gastroenterology (2010) 2.08

T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology (2002) 2.06

Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia. Am J Gastroenterol (2009) 2.05

Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res (2005) 2.05

Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis (2007) 1.94

Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut (2006) 1.92

Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo. Gut (2010) 1.92

Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Gastroenterology (2008) 1.88

Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol (2010) 1.86

Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis (2013) 1.85

IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur J Immunol (2007) 1.84

Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. J Rheumatol (2009) 1.84

Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J Exp Med (2010) 1.80

Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells. Blood (2009) 1.78

Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells. J Immunol (2007) 1.78

Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med (2006) 1.78